This article reflects Allergan Aesthetics' June 16, 2026 approval announcement and product safety information as of November 2026. It is educational and is not medical advice.
Horizontal lines across the front of the neck, sometimes called "tech neck," are a common complaint and one that injectors have had few approved options for. On June 16, 2026, Allergan Aesthetics, an AbbVie company, announced FDA approval of SKINVIVE by JUVÉDERM "to reduce neck lines for the improvement of neck appearance in adults over the age of 21." The company says it's the first hyaluronic acid (HA) injectable approved for that use.
What SKINVIVE is
SKINVIVE is an HA injectable with a small amount of lidocaine, a numbing agent. It's a skin-quality treatment, not a volumizing filler: it's placed in small amounts in the skin to help it hold moisture, rather than to lift or add structure. It was first approved in 2023 to improve the smoothness of the cheeks. The neck is its second approved area.
If you're unsure how skin boosters differ from fillers, see our guide to skin boosters vs. dermal fillers.
What the study showed
According to Allergan's announcement, the approval rested on a randomized, multicenter, evaluator-blinded, controlled study that graded neck lines on a five-point photo scale:
•One month: 74.8% of participants treated in the neck improved by at least one point on the scale.
•Six months: 66% (64 of 97) still had at least a one-point improvement.
•Touch-up: treatment could include an optional touch-up one month after the first session, depending on need. The company says results last six months "with optimal treatment."
A one-point change on a five-point scale is a modest, visible softening, not erasure. Deep, etched lines and loose neck skin are different problems, and SKINVIVE isn't approved to tighten skin.
How treatment works
Your injector places small amounts with an ultrafine needle or a cannula. Allergan describes it as minimally invasive with little to no downtime. Its aftercare guidance says to avoid makeup for 12 hours and to limit strenuous exercise, sun or heat exposure, and alcohol for 24 hours.
Allergan says providers must complete an FDA-required training program before buying and using SKINVIVE. It's reasonable to ask whether yours has.
Side effects and who shouldn't get it
The company lists the common side effects as injection-site redness, bruising, tenderness, lumps or bumps, swelling, firmness, pain, discoloration and itching, usually mild and gone within two weeks.
Like any HA injectable, it carries a rare but serious risk: accidental injection into a blood vessel, which can cause vision problems, blindness, stroke or permanent scarring. That's one reason training and anatomy knowledge matter.
According to the safety information, you shouldn't get SKINVIVE if you have a history of multiple severe allergies or anaphylaxis, are allergic to lidocaine or to the Gram-positive bacterial proteins used to make it, or have had an allergic reaction to HA fillers. Treatment should be postponed if you have sores, pimples, rashes, cysts or infection in the area. Safety hasn't been established in pregnancy or breastfeeding, and Allergan notes that people with darker skin tones weren't studied for the neck. Tell your injector if you take blood thinners or have a history of excessive scarring or pigment problems.
Questions to ask your injector
•Have you completed Allergan's SKINVIVE training, and how many neck treatments have you done?
•Am I a good candidate, or is my concern loose skin rather than lines?
•How many syringes do you expect for my neck, and what's the total cost including a touch-up?
•Will you use a needle or a cannula, and why?
•What's your plan if I have a vascular complication?
Before you book, our guide to verifying an aesthetic provider shows how to check a license.
This article is educational and does not constitute medical advice. Always consult a licensed medical professional for personalized recommendations.
Looking for an injectables provider?